Indapamide enhances the protective action of carbamazepine, phenobarbital, and valproate against maximal electroshock-induced seizures in mice

Advances in Medical Sciences

Volumn 54, Issue 1, 2009, Pages

  Kozinska, J ^a   Sawicka, K M ^a   Zadrozniak, A ^a   Wojda, E ^a   Andres Mach, M ^b   Dudra Jastrzebska, M ^a,b   Luszczki, J J ^a,b  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^b INSTITUTE OF AGRICULTURAL MEDICINE   (Poland)

Author keywords

Antiepileptic drugs; Indapamide; Maximal electroshock induced seizures; Pharmacodynamic interactions; Pharmacokinetic interactions

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; INDAPAMIDE; LAMOTRIGINE; OXCARBAZEPINE; PHENOBARBITAL; TOPIRAMATE; VALPROIC ACID; ANTIHYPERTENSIVE AGENT; DIURETIC AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTICONVULSANT ACTIVITY; ARTICLE; BRAIN PROTECTION; CONTROLLED STUDY; CONVULSION; DRUG BRAIN LEVEL; DRUG DOSE COMPARISON; DRUG POTENTIATION; DRUG SELECTIVITY; ELECTRIC SHOCK; LONG TERM MEMORY; MALE; MICROELECTRODE; MOTOR PERFORMANCE; MOUSE; MUSCLE STRENGTH; NONHUMAN; SEIZURE THRESHOLD; SKELETAL MUSCLE; ANIMAL; DRUG COMBINATION; EPILEPSY; INTRAPERITONEAL DRUG ADMINISTRATION; RANDOMIZATION; SEIZURE; STATISTICS;

ANIMALS; ANTICONVULSANTS; ANTIHYPERTENSIVE AGENTS; DIURETICS; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; ELECTROSHOCK; EPILEPSY; INDAPAMIDE; INJECTIONS, INTRAPERITONEAL; MALE; MICE; RANDOM ALLOCATION; SEIZURES; STATISTICS AS TOPIC;

EID: 66149093807     PISSN: 18961126     EISSN: None     Source Type: Journal    
DOI: 10.2478/v10039-009-0004-9     Document Type: Article

References (26)

1. Kyncl J. Oheim K. Seki T. Solles A. Antihypertensive action of indapamide. Comparative studies in several experimental models. Arzneimittelforschung. 1975 Oct; 25 (10): 1491-5.
2. Miyazaki M. Morishita S. Toda N. Vasodilator effect of indapamide in dog mesenteric vasculature. Jpn J Pharmacol. 1985 Nov; 39 (3): 402-5. (Pubitemid 16252564)
3. Rendu F. Bachelot C. Molle D. Caen J. Guez D. Indapamide inhibits human platelet aggregation in vitro: comparison with hydrochlorothiazide. J Cardiovasc Pharmacol. 1993; 22 Suppl 6: S57-63. (Pubitemid 23346738)
4. Tamura A. Sato T. Fujii T. Antioxidant activity of indapamide and its metabolite. Chem Pharm Bull (Tokyo). 1990 Jan; 38 (1): 255-7. (Pubitemid 20138408)
5. Uehara Y. Shirahase H. Nagata T. Ishimitsu T. Morishita S. Osumi S. Matsuoka H. Sugimoto T. Radical scavengers of indapamide in prostacyclin synthesis in rat smooth muscle cell. Hypertension. 1990 Feb; 15 (2): 216-24. (Pubitemid 20072505)
6. Zempel G. Ditlevsen J. Hoch M. Emerich U. Heinle H. Schiavi P. Dubois F. Lang F. Effects of indapamide on Ca2+ entry into vascular smooth muscle cells. Nephron. 1997; 76 (4): 460-5. (Pubitemid 27353190)
7. Lu Y. Yue L. Wang Z. Nattel S. Effects of the diuretic agent indapamide on Na+, transient outward, and delayed rectifier currents in canine atrial myocytes. Circ Res. 1998 Jul. 27; 83 (2): 158-66. (Pubitemid 28354460)
8. Hesdorffer D. C. Hauser W. A. Annegers J. F. Rocca W. A. Severe, uncontrolled hypertension and adult-onset seizures: a case-control study in Rochester Minnesota. Epilepsia. 1996 Aug; 37 (8): 736-41. (Pubitemid 26276941)
9. Ng S. K. Hauser W. A. Brust J. C. Susser M. Hypertension and the risk of new-onset unprovoked seizures. Neurology. 1993 Feb; 43 (2): 425-8. (Pubitemid 23060285)
10. Shapiro I. M. Neufeld M. Y. Korczyn A. D. Seizures of unknown origin after the age of 50: vascular risk factors. Acta NeurolScand. 1990 Jul; 82 (1): 78-80. (Pubitemid 20249256)
11. Chapman M. D. Hanrahan R. McEwen J. Marley J. E. Hyponatraemia and hypokalaemia due to indapamide. Med J Aust. 2002 Mar. 4; 176 (5): 219-21. (Pubitemid 34201931)
12. Luszczki J. J. Sawicka K. M. Kozinska J. Borowicz K. K. Czuczwar S. J. Furosemide potentiates the anticonvulsant action of valproate in the mouse maximal electroshock seizure model. Epilepsy Res. 2007 Aug; 76 (1): 66-72. (Pubitemid 47238597)
13. Luszczki J. J. Sawicka K. M. Kozinska J. Dudra-Jastrzebska M. Czuczwar S. J. Amiloride enhances the anticonvulsant action of various antiepileptic drugs in the mouse maximal electroshock seizure model. J Neural Transm. 2009 Jan; 116 (1): 57-66.
14. Löscher W. Fassbender C. P. Nolting B. The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. II. Maximal electroshock seizure models. Epilepsy Res. 1991 Mar; 8 (2): 79-94.
15. Luszczki J. J. Czernecki R. Wojtal K. Borowicz K. K. Czuczwar S. J. Agmatine enhances the anticonvulsant action of phenobarbital and valproate in the mouse maximal electroshock seizure model. J Neural Transm. 2008 Nov; 115 (11): 1485-94.
16. Luszczki J. J. Danysz W. Czuczwar S. J. Interactions of MRZ 2/576 with felbamate, lamotrigine, oxcarbazepine and topiramate in the mouse maximal electroshock-induced seizure model. Pharmacology. 2008; 81 (3): 259-65.
17. Lettieri J. T. Portelli S. T. Effects of competitive red blood cell binding and reduced hematocrit on the blood and plasma levels of [14C] Indapamide in the rat. J Pharmacol Exp Ther. 1983 Feb; 224 (2): 269-72.
18. Litchfield J. T. Jr Wilcoxon F. A simplified method of evaluating dose-effect experiments. J Pharmacol Exp Ther. 1949 Jun; 96 (2): 99-113.
19. Luszczki J. J. Ratnaraj N. Patsalos P. N. Czuczwar S. J. Isobolographic analysis of interactions between loreclezole and conventional antiepileptic drugs in the mouse maximal electroshock-induced seizure model. Naunyn-Schmiedebergs Arch Pharmacol. 2006 May; 373 (2): 169-81. (Pubitemid 43742442)
20. Boissier J. R. Tardy J. Diverres J. C. Une nouvelle méthode simple pour explorer Faction tranquilisante: le test de la cheminée. Med Exp. 1960; 3 (1): 81-4.
21. Meyer O. A. Tilson H. A. Byrd W. C. Riley M. T. A method for the routine assessment of fore- and hindlimb grip strength of rats and mice. Neurobehav Toxicol. 1979 Fall; 1 (3): 233-6. (Pubitemid 11204691)
22. Luszczki J. J. Czuczwar S. J. Isobolographic characterization of interactions between vigabatrin and tiagabine in two experimental models of epilepsy. Prog Neuropsychopharmacol Biol Psychiatry. 2007 Mar. 30; 31 (2): 529-38. (Pubitemid 46209449)
23. Venault P. Chapouthier G. de Carvalho L. P. Simiand J. Morre M. Dodd R. H. Rossier J. Benzodiazepine impairs and beta-carboline enhances performance in learning and memory tasks. Nature 1986 Jun. 26-Jul; 321 (6073): 864-6. (Pubitemid 16097728)
24. Luszczki J. J. Swiader M. Parada-Turska J. Czuczwar S. J. Tiagabine synergistically interacts with gabapentin in the electroconvulsive threshold test in mice. Neuropsychopharmacology. 2003 Oct; 28 (10): 1817-30. (Pubitemid 41070847)
25. Luszczki J. J. Wojcik-Cwikla J. Andres M. M. Czuczwar S. J. Pharmacological and behavioral characteristics of interactions between vigabatrin and conventional antiepileptic drugs in pentylenetetrazole-induced seizures in mice: an isobolographic analysis. Neuropsychopharmacology. 2005 May; 30 (5): 958-73. (Pubitemid 40570911)
26. Luszczki J. J. Czuczwar S. J. Preclinical profile of combinations of some second-generation antiepileptic drugs: an isobolographic analysis. Epilepsia. 2004 Aug; 45 (8): 895-907. (Pubitemid 39062811)